Literature DB >> 14504715

Bone strength in primary hyperparathyroidism.

John P Bilezikian.   

Abstract

In primary hyperparathyroidism, as is the case for any metabolic bone disease like osteoporosis, bone strength is a function of many variables. In addition to bone density, considerations of bone size, microarchitecture, and dynamic variables related to the evolution of the disease are all likely to influence bone strength. With greater tools to investigate these points and with newly identified cohorts of this disease, some of whom are presenting with the earliest manifestations of abnormal parathyroid function, it is expected that fresh insights will emerge. Greater knowledge of the disease should help in understanding anabolic aspects of PTH when it is used as a treatment for osteoporosis.

Entities:  

Mesh:

Year:  2003        PMID: 14504715     DOI: 10.1007/s00198-003-1482-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  10 in total

Review 1.  Clinical review 137: Sexual dimorphism in skeletal size, density, and strength.

Authors:  E Seeman
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

Review 2.  Parathyroid hormone and periosteal bone expansion.

Authors:  A Michael Parfitt
Journal:  J Bone Miner Res       Date:  2002-10       Impact factor: 6.741

Review 3.  Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Bethesda, Maryland, October 29-31, 1990.

Authors: 
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

4.  Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism.

Authors:  S J Silverberg; F G Locker; J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1996-11       Impact factor: 5.958

5.  Bone measurements in asymptomatic primary hyperparathyroidism.

Authors:  S Adami; V Braga; R Squaranti; M Rossini; D Gatti; N Zamberlan
Journal:  Bone       Date:  1998-05       Impact factor: 4.398

6.  Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course.

Authors:  D S Rao; R J Wilson; M Kleerekoper; A M Parfitt
Journal:  J Clin Endocrinol Metab       Date:  1988-12       Impact factor: 5.958

7.  Primary hyperparathyroidism and the risk of fracture: a population-based study.

Authors:  S Khosla; L J Melton; R A Wermers; C S Crowson; W m O'Fallon; B l Riggs
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

8.  A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.

Authors:  S J Silverberg; E Shane; T P Jacobs; E Siris; J P Bilezikian
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

9.  "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease.

Authors:  Shonni J Silverberg; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

10.  Risk of age-related fractures in patients with primary hyperparathyroidism.

Authors:  L J Melton; E J Atkinson; W M O'Fallon; H Heath
Journal:  Arch Intern Med       Date:  1992-11
  10 in total
  10 in total

Review 1.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

2.  The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84).

Authors:  Katherine Wesseling-Perry; G Chris Harkins; He-jing Wang; Robert Elashoff; Barbara Gales; Mara J Horwitz; Andrew F Stewart; Harald Jüppner; Isidro B Salusky
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

3.  New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone.

Authors:  Thuy D T Vu; Xiao Fang Wang; Qingju Wang; Natalie E Cusano; Dinaz Irani; Barbara C Silva; Ali Ghasem-Zadeh; Julia Udesky; Megan E Romano; Roger Zebaze; George Jerums; Stephanie Boutroy; John P Bilezikian; Ego Seeman
Journal:  Bone       Date:  2013-03-26       Impact factor: 4.398

4.  Bone fragility: current reviews and clinical features.

Authors:  Paolo Tranquilli Leali; Carlo Doria; Alexandros Zachos; Adriano Ruggiu; Fabio Milia; Francesca Barca
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

5.  Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.

Authors:  Emily M Stein; Barbara C Silva; Stephanie Boutroy; Bin Zhou; Ji Wang; Julia Udesky; Chiyuan Zhang; Donald J McMahon; Megan Romano; Elzbieta Dworakowski; Aline G Costa; Natalie Cusano; Dinaz Irani; Serge Cremers; Elizabeth Shane; X Edward Guo; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

Review 6.  The role of bone biopsy in patients with chronic renal failure.

Authors:  Paul D Miller
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

7.  Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism.

Authors:  Symeon Tournis; Eleni Fakidari; Ismene Dontas; Chrysoula Liakou; Julia Antoniou; Antonis Galanos; Helen Marketou; Konstantinos Makris; Katerina Katsalira; George Trovas; George P Lyritis; Nikolaos Papaioannou
Journal:  J Bone Miner Metab       Date:  2013-05-23       Impact factor: 2.626

8.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

9.  The Risk of Fractures in Primary Hyperparathyroidism: A Meta-Analysis.

Authors:  Niya Narayanan; Rajan Palui; Chandhana Merugu; Sitanshu Sekhar Kar; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Sandhiya Selvarajan; Dukhabandhu Naik
Journal:  JBMR Plus       Date:  2021-03-16

10.  A Diagnosis of Normocalcemic Primary Hyperparathyroidism Prompted by "Salt and Pepper" Lesions of the Calvarium.

Authors:  Simrun K Bal; Meredith J Sorensen; Andrew Robert Crawford
Journal:  AACE Clin Case Rep       Date:  2021-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.